Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: An ROS-sensitive tegafur-PpIX-heterodimer-loaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer
Zhiqiang Zhanga,
Anning Lib,
Xingqi Mina,
Qunqun Zhanga,
Jun Yanga,
Guo Chena,
Meijuan Zoua,
Wei Sun*c and
Gang Cheng*a
aDepartment of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China. E-mail: chenggang63@hotmail.com; Tel: +8613998331395
bWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
cDepartment of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, PR China. E-mail: sunwei19801208@163.com; Tel: +8618341400226
First published on 5th May 2026
Abstract
Correction for ‘An ROS-sensitive tegafur-PpIX-heterodimer-loaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer’ by Zhiqiang Zhang et al., Biomater. Sci., 2021, 9, 221–237, https://doi.org/10.1039/D0BM01519A.
The authors regret the error in Fig. 6G in the original manuscript. The correct version of Fig. 6G is as shown below.
 | ||
| Fig. 6 Intracellular TF release and the 4T1 cell cellular uptake (n = 3). (G) The cellular uptake of hydrogels with/without laser irradiation imaged via CSLM. *: p < 0.05, significant difference; **: p < 0.01, extremely significant difference; n.s.: p > 0.05, no significance. Scale bar = 10 μm. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |